| 1 |
Abate ML, Caviglia GP. Chronic Hepatitis C: Pathophysiology and Clinical Issues. Biology (Basel) 2022;11. [PMID: 36552247 DOI: 10.3390/biology11121737] [Reference Citation Analysis]
|
| 2 |
Salama II, Raslan HM, Abdel-Latif GA, Salama SI, Sami SM, Shaaban FA, Abdelmohsen AM, Fouad WA. Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection. World J Hepatol 2022; 14(6): 1053-1073 [DOI: 10.4254/wjh.v14.i6.1053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Cusato J, Calcagno A, Antonucci M, Marinaro L, Avataneo V, De Nicolò A, Bonora S, Di Perri G, D’avolio A. A pharmacogenetic study in HIV-infected patients treated with ritonavir: hematological and cardiovascular disease risk analysis. Minerva Biotechnol Biomol Res 2022;33. [DOI: 10.23736/s2724-542x.20.02739-1] [Reference Citation Analysis]
|
| 4 |
Derbak MA, Vorobets VV, Griga VI. CORRECTION OF INTESTINAL DYSBIOSIS IN PATIENTS WITH CHRONIC HEPATITIS C AGAINST THE BACKGROUND OF NON-ALCOHOLIC FATTY LIVER DISEASE. VPBM 2022;1:160. [DOI: 10.29254/2077-4214-2022-3-166-160-164] [Reference Citation Analysis]
|
| 5 |
Priora M, Borrelli R, Parisi S, Ditto MC, Realmuto C, Laganà A, Centanaro Di Vittorio C, Degiovanni R, Peroni CL, Fusaro E. Autoantibodies and Rheumatologic Manifestations in Hepatitis C Virus Infection. Biology (Basel) 2021;10:1071. [PMID: 34827064 DOI: 10.3390/biology10111071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 6 |
Cardoso AC, de Figueiredo-Mendes C, A Villela-Nogueira C. Current management of NAFLD/NASH. Liver Int 2021;41 Suppl 1:89-94. [PMID: 34155799 DOI: 10.1111/liv.14869] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 7 |
Caviglia GP, Rosso C, Armandi A, Ribaldone DG, Pellicano R, Bugianesi E. Analytical and clinical comparison between two different chemiluminescent enzyme immunoassays for the measurement of C-peptide in serum. Minerva Biotechnol Biomol Res 2021;33. [DOI: 10.23736/s2724-542x.20.02710-x] [Reference Citation Analysis]
|
| 8 |
Pellicano R, Oliaro A. Non-transplant surgery in patients with liver disease: essential key messages to be remembered. Chirurgia 2021;33. [DOI: 10.23736/s0394-9508.20.05198-0] [Reference Citation Analysis]
|
| 9 |
Armandi A, Caviglia GP, Saracco GM, De Marco L, Fagoonee S, Pellicano R. Seronegative occult hepatitis C virus infection: what is its clinical relevance? Minerva Biotecnol 2020;32. [DOI: 10.23736/s1120-4826.20.02637-3] [Reference Citation Analysis]
|
| 10 |
Hassan M, Aboushousha T, El-Ahwany E, Khalil HK, Montasser AY, Abu-Taleb H, El-Talkawy MD, Zoheiry M. Impact of E-cadherin and its transcription regulators on assessing epithelial-mesenchymal transition in chronic hepatitis C virus infection. Minerva Gastroenterol (Torino) 2021;67:175-82. [PMID: 32677416 DOI: 10.23736/S2724-5985.20.02687-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 11 |
Suciu A, Abenavoli L, Pellicano R, Luzza F, Dumitrascu DL. Transaminases: oldies but goldies. A narrative review. Minerva Gastroenterol Dietol 2020;66:246-51. [PMID: 31994373 DOI: 10.23736/S1121-421X.20.02660-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 12 |
Gentilcore E. Long-term outcomes after hepatitis C virus eradication: a message for clinicians. Minerva Med 2020;110. [DOI: 10.23736/s0026-4806.19.06211-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
